News Categories: Pharmacy Law

September 2019

Racketeering Lawsuit Against Cannabis Company Proceeds

While marijuana continues to become legal in more and more states, business owners should be aware of some in their communities who view them as no better than traditional criminal organizations. Multiple lawsuits brought against cannabis companies under the Civil Racketeer Influenced and Corrupt Organizations Act – better known as

October 2019

FBMJ Attorneys Featured Speakers at U of M College of Pharmacy Event

FBMJ attorneys, Kim Sveska, RPh, MS, JD and Eric Nordan, RPh, PharmD, JD, presented “Current Status of Marijuana in Michigan” to more than 200 members of the University of Michigan College of Pharmacy on October 4, 2019, at the Tom D. Rowe 68th Annual Pharmacy Lectures in Ann Arbor, Michigan.

June 2019

FBMJ’s Rx Attorney, Sveska, Featured Speaker at SMSHP Event

FBMJ pharmacist-attorney Kim Sveska presented “Legal and Ethical Issues Regarding Recreational Marijuana” to pharmacy technicians of the Southeastern Michigan Society of Health-System Pharmacists (SMSHP) on June 1, 2019, at the Hellenic Cultural Center in Westland, Michigan.  The lecture provided an overview of the new Michigan Regulation and Taxation of Marijuana

June 2019

Documentation Beats Conversation

Are you properly documenting prescriber interventions before dispensing opioids to your patients? Documentation must support a pharmacist’s professional judgment with clarity and specificity.  During a recent Michigan Board of Pharmacy (BOP) inspection, the state inspector advised caution to the pharmacy staff regarding opioid dispensing and documentation of opioid prescription interventions,  referencing

May 2019

State Clarifies “Applicants” for Marijuana Licensure

The Michigan legislature has given further guidance to individuals and businesses interested in obtaining a license for or participating in a new marijuana business. Public Act 3 of 2019, signed into law in April 2019, has clarified the confusion over who is considered an “Applicant” for application disclosure purposes on

May 2019

New Steps to Advance FDA’s Evaluation of CBD

The Food and Drug Administration (FDA) is moving forward with evaluating ways to allow cannabis and cannabis-derived products like cannabidiol (CBD) into foods, beverages, and dietary supplements. A public hearing will be held on May 31, 2019 at its White Oak Campus in Silver Spring, Maryland to discuss ways to

April 2019

Cannabidiol & Cosmetics – Changing Federal & State Regulations

Based on recent enforcement actions and rule changes at the state and federal levels, the focus on cannabidiol (CBD), the non-psychoactive component of both hemp and marijuana, as an additive to consumer products is on consumable products such as foods, beverages, and dietary supplements rather than topical products such as

February 2019

State Allows Provisioning Center to Reopen, Sell Untested Marijuana

There were four recalls of marijuana in January 2019 while more than 70 unlicensed provisioning centers were permitted to reopen as the state continues to struggle to find a balance of making marijuana available to those with a medical need and to ensure all provisioning centers that dispense such marijuana

November 2017

Cannabis Licenses Carry High Capitalization Costs

As has long been suspected, the state announced last week that those seeking licenses from the Michigan Bureau of Medical Marihuana Regulation (BMMR) beginning in December will undergo an evaluation of their capitalization. In other words, the state intends to evaluate an applicant’s ability to operate and maintain a marijuana

November 2017

Medical Marijuana Dispensaries Can Continue to Operate

After more than two months of mixed signals, current medical marijuana users in Michigan will be relieved to hear that the Michigan Bureau of Medical Marihuana Regulation (BMMR) will not force existing dispensaries to close prior to the implementation of the Medical Marihuana Facilities Licensing Act (MMFLA) next month. The